Purdue Pharma’s Payments to Sacklers Soared Amid Opioid Crisis

A new audit finds that the family directed $10.7 billion from the drugmaker to family-controlled trusts and holding companies, as legal pressure tightened around Purdue.
By BY JAN HOFFMAN AND DANNY HAKIM from NYT Health https://ift.tt/35taG0z
via IFTTT
Suits and Litigation (Civil), Bankruptcies, Pain-Relieving Drugs, Opioids and Opiates, Corporate Taxes, your-feed-healthcare
Source New York Times
Làm đẹp Blog 247